Resum
The present perspective paper shortly and specifically addresses the issues of whether inhibition of GABA-A receptor-mediated synaptic transmission may be involved in antidepressant-like actions and the therapeutic effects of conventional antidepressant (AD) drugs, and whether the recent development of negative allosteric modulators (NAMs) of the alpha5-GABA-A receptor may constitute significant progress in our knowledge on the neurobiology and the treatment of depression.
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 85-89 |
Nombre de pàgines | 5 |
Revista | Current Neuropharmacology |
Volum | 20 |
DOIs | |
Estat de la publicació | Publicada - 2022 |